Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China

World News: . []

COPENHAGEN Denmark Nov 08 2018 GLOBE NEWSWIRE -- Ascendis Pharma AS Nasdaq ASND a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs today announced the formation of VI SEN Pha...

More news and information about Ascendis Pharma A/S

Published By:

Globe Newswire: 21:48 GMT Thursday 8th November 2018

Published: .

Search for other references to "ascendis" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us